市場調査レポート

商品コード

インクレチン関連薬の世界市場：医薬品タイプ別、投与経路別、適応症別、地域別、国別の分析、市場の考察と予測

Global Incretin Based Drugs Market : Analysis By Drug Type, Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast

出版日: 2023年12月01日
発行: Azoth Analytics
ページ情報: 英文 230 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 2,450 359,709円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 2,950 433,119円

レポートPDFを同一企業内の全員にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のインクレチン関連薬の市場規模は、2022年の407億2,000万米ドルから2029年末までに642億8,000万米ドルに達し、予測期間の2024年～2029年にCAGRで6.8%の成長が見込まれています。

世界の2型糖尿病の有病率の増加は、インクレチン関連薬の需要に大きな影響を与えています。糖尿病の罹患率の増加は、座りがちなライフスタイルや、食生活の乱れ、高齢化などのさまざまな要因に起因しています。

その他の多くの抗高血糖薬と比較して、インクレチン関連薬は低血糖や体重増加のリスクがないなど、いくつかの特筆すべき恩恵をもたらします。DPP4IとGLP-1RAは独自の有効性と忍容性プロファイルを示すため、医師は疾患の状態（HbA1cのパーセンテージで示される）、体重、自己注射薬に対する患者の選好などの要因を考慮しながら、それぞれの患者にもっとも適した薬剤を選択することができます。市場のブロックバスター医薬品がジェネリック医薬品として入手可能になり、投与回数を減らした改良の製剤が登場するにつれて、インクレチン関連薬の需要は飛躍的に伸びると予測されます。

当レポートでは、世界のインクレチン関連薬市場について調査し、市場規模と予測、地域とセグメントの分析、主な動向と機会などの情報を提供しています。

世界の肥満統計（2022年）
インクレチン関連薬のパイプライン分析
世界でもっとも糖尿病の有病率が高い国（2021年）
世界の糖尿病患者の推定人数（2000年～2014年E）
世界のインクレチン関連薬市場：ダッシュボード
世界のインクレチン関連薬市場：市場金額の評価（2018年～2028年）
世界のインクレチン関連薬市場に対するCOVID-19の影響
世界のインクレチン関連薬市場セグメンテーション：医薬品タイプ別
- 世界のインクレチン関連薬市場：医薬品タイプ別、概要
- 世界のインクレチン関連薬の市場規模、グルカゴン様ペプチド-1受容体作動薬（金額）（2018年～2028年）
- 世界のインクレチン関連薬の市場規模、ジペプチジルペプチダーゼ-4阻害薬（金額）（2018年～2028年）
世界のインクレチン関連薬市場セグメンテーション：投与経路別
- 世界のインクレチン関連薬市場：投与経路別、概要
- 世界のインクレチン関連薬の市場規模、経口（金額）（2018年～2028年）
- 世界のインクレチン関連薬の市場規模、注射（金額）（2018年～2028年）
世界のインクレチン関連薬市場セグメンテーション：適応症別
- 世界のインクレチン関連薬市場：適応症別、概要
- 世界のインクレチン関連薬の市場規模、糖尿病（金額）（2018年～2028年）
- 世界のインクレチン関連薬の市場規模、肥満（金額）（2018年～2028年）

第4章世界のインクレチン関連薬市場、地域分析

研究の地域範囲
地域のスナップショット

第5章南北アメリカのインクレチン関連薬市場：実績と予測（2018年～2028年）

南北アメリカのインクレチン関連薬市場：スナップショット
南北アメリカのインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
南北アメリカのインクレチン関連薬市場：主な要因
南北アメリカのインクレチン関連薬市場：セグメント分析
南北アメリカのインクレチン関連薬市場セグメンテーション：医薬品タイプ別
南北アメリカのインクレチン関連薬市場セグメンテーション：投与経路別
南北アメリカのインクレチン関連薬市場セグメンテーション：適応症別
南北アメリカのインクレチン関連薬市場セグメンテーション：国別
- 米国のインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
- カナダのインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
- その他の南北アメリカのインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）

第6章欧州のインクレチン関連薬市場：実績と予測（2018年～2028年）

欧州のインクレチン関連薬市場：スナップショット
欧州のインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
欧州のインクレチン関連薬市場：主な要因
欧州のインクレチン関連薬市場：セグメント分析
欧州のインクレチン関連薬市場セグメンテーション：医薬品タイプ別
欧州のインクレチン関連薬市場セグメンテーション：投与経路別
欧州のインクレチン関連薬市場セグメンテーション：適応症別
欧州のインクレチン関連薬市場セグメンテーション：国別
- ドイツのインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
- 英国のインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
- フランスのインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
- イタリアのインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
- スペインのインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
- その他の欧州のインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）

第7章アジア太平洋のインクレチン関連薬市場：実績と予測（2018年～2028年）

アジア太平洋のインクレチン関連薬市場：スナップショット
アジア太平洋のインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
アジア太平洋のインクレチン関連薬市場：主な要因
アジア太平洋のインクレチン関連薬市場：セグメント分析
アジア太平洋のインクレチン関連薬市場セグメンテーション：医薬品タイプ別
アジア太平洋のインクレチン関連薬市場セグメンテーション：投与経路別
アジア太平洋のインクレチン関連薬市場セグメンテーション：適応症別
アジア太平洋のインクレチン関連薬市場セグメンテーション：国別
- 中国のインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
- 日本のインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
- インドのインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
- その他のアジア太平洋のインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）

第8章中東・アフリカのインクレチン関連薬市場：実績と予測（2018年～2028年）

中東・アフリカのインクレチン関連薬市場：スナップショット
中東・アフリカのインクレチン関連薬市場：市場規模とCAGR（2018年～2028年）
中東・アフリカのインクレチン関連薬市場：主な要因
中東・アフリカのインクレチン関連薬市場：セグメント分析
中東・アフリカのインクレチン関連薬市場セグメンテーション：医薬品タイプ別
中東・アフリカのインクレチン関連薬市場セグメンテーション：投与経路別
中東・アフリカのインクレチン関連薬市場セグメンテーション：適応症別

第9章市場力学

世界のインクレチン関連薬市場に対する市場力学の影響の評価
促進要因
抑制要因
動向

第10章ポーターのファイブフォース分析

第11章競合のポジショニング

企業の製品ポジショニング
市場ポジションマトリクス
インクレチン関連薬市場の市場シェア分析
企業プロファイル
- Eli Lilly and Company
- Boehringer Ingelheim
- Novo Nordisk
- AstraZeneca PLC
- Merck & Co., Inc.
- Pfizer
- Novartis AG
- Takeda Pharmaceuticals
- Bristol Myers Squibb
- Structure Therapeutics

図表

List of Figures

Figure 1: Global obesity statistics 2022(In Millions)
Figure 2: Countries with the highest prevalence of diabetes worldwide in 2021
Figure 3: People with diabetes in Thousands, (20-79 y)
Figure 4: Global Incretin Based Drugs Market Size, By Value, 2019-2022 (USD Billion)
Figure 5: Global Incretin Based Drugs Market Size, By Value, 2023-2029 (USD Billion)
Figure 6: Global Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
Figure 7: Global Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 8: Global Incretin Based Drugs Market Absolute Opportunity, By Glucagon-like Peptide-1 Receptor Agonists, 2019-2029 (USD Billion)
Figure 9: Global Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 10: Global Incretin Based Drugs Market Absolute Opportunity, By Dipeptidyl Peptidase-4 Inhibitors, 2019-2029 (USD Billion)
Figure 11: Global Incretin Based Drugs Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 12: Global Incretin Based Drugs Market Absolute Opportunity, By Oral, 2019-2029 (USD Billion)
Figure 13: Global Incretin Based Drugs Market Size, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 14: Global Incretin Based Drugs Market Absolute Opportunity, By Injectables, 2019-2029 (USD Billion)
Figure 15: Global Incretin Based Drugs Market Size, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 16: Global Incretin Based Drugs Market Absolute Opportunity, By Diabetes, 2019-2029 (USD Billion)
Figure 17: Global Incretin Based Drugs Market Size, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 18: Global Incretin Based Drugs Market Absolute Opportunity, By Obesity, 2019-2029 (USD Billion)
Figure 19: Americas Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
Figure 20: Americas Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
Figure 21: Americas Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 22: Americas Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 23: Americas Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 24: Americas Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 25: Americas Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 26: Americas Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 27: United States Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 28: United States Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 29: United States Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 30: United States Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
Figure 31: United States Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 32: Canada Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 33: Canada Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 34: Canada Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 35: Canada Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 36: Canada Incretin Based Drugs Market Share, Indication, 2022 (%)
Figure 37: Rest of Americas Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 38: Rest of Americas Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 39: Rest of Americas Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 40: Rest of Americas Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 41: Rest of Americas Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 42: Europe Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
Figure 43: Europe Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
Figure 44: Europe Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 45: Europe Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 46: Europe Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 47: Europe Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 48: Europe Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 49: Europe Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 50: Germany Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 51: Germany Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 52: Germany Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 53: Germany Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
Figure 54: Germany Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 55: United Kingdom Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 56: United Kingdom Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 57: United Kingdom Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 58: United Kingdom Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
Figure 59: United Kingdom Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 60: France Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 61: France Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 62: France Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 63: France Incretin Based Drugs Market Share, By Route of Administration, By Value, 2022 (%)
Figure 64: France Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 65: Italy Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 66: Italy Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 67: Italy Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 68: Italy Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 69: Italy Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 70: Spain Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 71: Spain Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 72: Spain Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 73: Spain Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 74: Spain Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 75: Rest of Europe Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 76: Rest of Europe Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 77: Rest of Europe Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 78: Rest of Europe Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 79: Rest of Europe Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 80: Asia Pacific Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
Figure 81: Asia Pacific Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
Figure 82: Asia Pacific Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 83: Asia Pacific Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 84: Asia Pacific Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 85: Asia Pacific Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 86: Asia Pacific Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 87: Asia Pacific Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 88: China Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 89: China Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 90: China Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 91: China Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 92: China Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 93: Japan Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 94: Japan Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 95: Japan Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 96: Japan Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 97: Japan Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 98: India Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 99: India Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 100: India Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 101: India Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 102: India Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 103: Rest of Asia Pacific Incretin Based Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 104: Rest of Asia Pacific Incretin Based Drugs Market Value, By Drug Type, 2022 (USD Billion)
Figure 105: Rest of Asia Pacific Incretin Based Drugs Market Share, By Drug Type, By Value, 2022 (%)
Figure 106: Rest of Asia Pacific Incretin Based Drugs Market Share, By Route of Administration, 2022 (%)
Figure 107: Rest of Asia Pacific Incretin Based Drugs Market Share, By Indication, 2022 (%)
Figure 108: Middle East and Africa Incretin Based Drugs Market Size, By Value, 2019H-2029F (USD Billion)
Figure 109: Middle East and Africa Incretin Based Drugs Market Share, By Drug Type, 2022 (%)
Figure 110: Middle East and Africa Incretin Based Drugs Market, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 111: Middle East and Africa Incretin Based Drugs Market, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 112: Middle East and Africa Incretin Based Drugs Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 113: Middle East and Africa Incretin Based Drugs Market, By Injectables, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 114: Middle East and Africa Incretin Based Drugs Market, By Diabetes, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 115: Middle East and Africa Incretin Based Drugs Market, By Obesity, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 116: Market Share of Prominent Companies of Incretin Based Drugs Market, 2022 (%)
Figure 117: Eli Lilly and Company Revenues, 2020-2022 (USD Million)
Figure 118: Eli Lilly and Company Revenues, By Geographic Segments, 2022 (%)
Figure 119: Eli Lilly and Company Revenue, By Therapeutic Area, 2022 (%)
Figure 120: Novo Nordisk Revenues, 2020-2022 (USD Million)
Figure 121: Novo Nordisk Revenues, By Geographic Segments, 2022 (%)
Figure 122: Novo Nordisk Revenue, By Therapeutic Area, 2022 (%)
Figure 123: AstraZeneca PLC Revenues, 2020-2022 (USD Million)
Figure 124: AstraZeneca PLC Revenues, By Geographic Segments, 2022 (%)
Figure 125: AstraZeneca PLC Revenue, By Business Segments, 2022 (%)
Figure 126: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
Figure 127: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
Figure 128: Merck & Co., Inc. Revenue, By Business Segments, 2022 (%)
Figure 129: Pfizer Revenues, 2020-2022 (USD Million)
Figure 130: Pfizer Revenues, By Business Segments, 2022 (%)
Figure 131: Pfizer Inc. Revenue, By Geographical Segments, 2022 (%)
Figure 132: Novartis Revenue, 2020-2022 (USD Million)
Figure 133: Novartis Revenue, By Business Segments, 2022 (%)
Figure 134: Novartis Revenue, By Geographical Segments, 2022 (%)
Figure 135: Takeda Pharmaceuticals Revenues, 2019-2021 (USD Million)
Figure 136: Takeda Pharmaceuticals Revenues, By Geographic Segments, 2021 (%)
Figure 137: Takeda Pharmaceuticals Revenue, By Business Segments, 2021 (%)
Figure 138: Bristol-Myers Squibb Revenues, 2020-2022 (USD Million)
Figure 139: Bristol-Myers Squibb Revenues, By Geographic Segments, 2022 (%)

List of Tables

Table A1: Incretin based drugs in Several stages of clinical trials

Table A2: United States Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A3: United States Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A4: United States Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A5: United States Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A6: United States Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A7: United States Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A8: Canada Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A9: Canada Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A10: Canada Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A11: Canada Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A12: Canada Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A13: Canada Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A14: Rest of Americas Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A15: Rest of Americas Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A16: Rest of Americas Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A17: Rest of Americas Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A18: Rest of Americas Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A19: Rest of Americas Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A20: Germany Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A21: Germany Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A22: Germany Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A23: Germany Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A24: Germany Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A25: Germany Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A26: United Kingdom Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A27: United Kingdom Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A28: United Kingdom Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A29: United Kingdom Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A30: United Kingdom Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A31: United Kingdom Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A32: France Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A33: France Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A34: France Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A35: France Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A36: France Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A37: France Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A38: Italy Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A39: Italy Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A40: Italy Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A41: Italy Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A42: Italy Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A43: Italy Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A44: Spain Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A45: Spain Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A46: Spain Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A47: Spain Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A48: Spain Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A49: Spain Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A50: Rest of Europe Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A51: Rest of Europe Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A52: Rest of Europe Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A53: Rest of Europe Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A54: Rest of Europe Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A55: Rest of Europe Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A56: China Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A57: China Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A58: China Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A59: China Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A60: China Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A61: China Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A62: Japan Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A63: Japan Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A64: Japan Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A65: Japan Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A66: Japan Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A67: Japan Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A68: India Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A69: India Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A70: India Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A71: India Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A72: India Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A73: India Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A74: Rest of Asia Pacific Incretin Based Drugs Market, By Drug Type, By Value, 2019-2022 (USD Billion)

Table A75: Rest of Asia Pacific Incretin Based Drugs Market, By Drug Type, By Value, 2023-2029 (USD Billion)

Table A76: Rest of Asia Pacific Incretin Based Drugs Market, By Route of Administration, By Value, 2019-2022 (USD Billion)

Table A77: Rest of Asia Pacific Incretin Based Drugs Market, By Route of Administration, By Value, 2023-2029 (USD Billion)

Table A78: Rest of Asia Pacific Incretin Based Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A79: Rest of Asia Pacific Incretin Based Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A80: Eli Lilly and Company Key Financials, 2020-2022

Table A81: Novo Nordisk Key Financials, 2020-2022

Table A82: AstraZeneca PLC Key Financials, 2020-2022

Table A83: Merck & Co., Inc. Key Financials, 2020-2022

Table A84: Pfizer Key Financials, 2020-2022

Table A85: Novartis Key Company Financials, 2020-2022

Table A86: Takeda Pharmaceuticals Key Financials, 2020-2022

Table A87: Bristol-Myers Squibb Key Financials, 2020-2022

Executive Summary

Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), By Route of Administration (Oral, Injectables) and By Indication (Diabetes, Obesity) for the historical period of 2018-2022, the estimated year of 2023 and the forecast period of 2024-2028.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.

During the forecast period, 2024-2029, the Global Incretin Based Drugs market is expected to grow at a CAGR of 6.8%. The Global Incretin Based Drugs Market is expected to generate USD 64.28 billion by the end of 2029, up from USD 40.72 Billion in 2022.

Incretin-based drugs are the first-of-its-kind anti-hyperglycemic medications that have been developed by specifically targeting a recognized pathophysiological abnormality in type 2 diabetes. The global increase in the prevalence of type 2 diabetes has a significant impact on the demand for incretin-based drugs. The growing incidence of diabetes can be attributed to various factors, including sedentary lifestyles, poor dietary habits, and the ageing demographic.

In comparison to many other anti-hyperglycemic medications, incretin-based drugs offer some notable benefits, including the lack of an elevated risk of hypoglycemia or weight gain. The DPP4Is and GLP-1RAs exhibit unique efficacy and tolerability profiles, providing physicians with the opportunity to choose the most suitable medication for each patient, taking into account factors such as disease status (as indicated by HbA1c percentage), body weight, and patient preference for self-administered injectable drugs. The demand for Incretin-based drugs is expected to grow exponentially as the blockbuster drugs in the market become accessible in generic form and as upgraded formulations with reduced dosing frequency are introduced.

Scope of the Report

The report analyses the Incretin Based Drugs Market by Value (USD Billion).
The report presents the analysis of Incretin Based Drugs Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
The report analyses the Incretin-Based Drugs Market by Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors).
The report analyses the Incretin Based Drugs Market by Route of Administration (Oral, Injectables)
The report analyses the Incretin-Based Drugs Market by Indication (Diabetes, Obesity).
The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Drug Type, By Route of Administration and by Indications.
Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk, AstraZeneca PLC, Merck & Co., Inc., Pfizer, Novartis AG, Takeda Pharmaceuticals, Bristol Myers Squibb, Structure Therapeutics.

1. Market Background

1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology

2. Strategic Recommendations

3. Global Incretin Based Drugs Market: Historic and Forecast (2018-2028)

3.1 Global Obesity Statistics 2022, in Millions
3.2 Pipeline Analysis of Incretin based drugs
3.3 Countries with the highest prevalence of diabetes worldwide in 2021
3.4 Estimated number of individuals with Diabetes Worldwide, in thousands (2000-2014E)
3.5 Global Incretin-Based Drugs Market: Dashboard
3.6 Global Incretin Based Drugs Market: Market Value Assessment, 2018-2028 (USD Billion)
3.7 Impact of COVID-19 on Global Incretin Based Drugs Market
3.8 Global Incretin-Based Drugs Market Segmentation: By Drug Type
- 3.8.1 Global Incretin-Based Drugs Market, By Drug Type Overview
- 3.8.2 Global Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
- 3.8.3 Global Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
3.9 Global Incretin-Based Drugs Market Segmentation: By Route of Administration
- 3.9.1 Global Incretin-Based Drugs Market, By Route of Administration Overview
- 3.9.2 Global Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
- 3.9.3 Global Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
3.10 Global Incretin Based Drugs Market Segmentation: By Indication
- 3.10.1 Global Incretin Based Drugs Market, By Indication Overview
- 3.10.2 Global Incretin Based Drugs Market Size, By Diabetes By Value, 2018H-2028F (USD Billion & CAGR)
- 3.10.3 Global Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)

4. Global Incretin Based Drugs Market, Region Analysis

4.1 Regional Coverage of the Study
4.2 Regional Snapshot

5. Americas Incretin Based Drugs Market: Historic and Forecast (2018-2028)

5.1 Americas Incretin-Based Drugs Market: Snapshot
5.2 Americas Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
5.3 Americas Incretin-Based Drugs Market: Key Factors
5.4 Americas Incretin-Based Drugs Market: Segment Analysis
5.5 Americas Incretin-Based Drugs Market Segmentation: By Drug Type
- 5.5.1 Americas Incretin-Based Drugs Market, By Drug Type Overview
- 5.5.2 Americas Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
- 5.5.3 Americas Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
5.6 Americas Incretin-Based Drugs Market Segmentation: By Route of Administration
- 5.6.1 Americas Incretin-Based Drugs Market, By Route of Administration Overview
- 5.6.2 Americas Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
- 5.6.3 Americas Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
5.7 Americas Incretin-Based Drugs Market Segmentation: By Indication
- 5.7.1 Americas Incretin-Based Drugs Market, By Indication Overview
- 5.7.2 Americas Incretin-Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
- 5.7.3 Americas Incretin-Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
5.8 Americas Incretin-Based Drugs Market Segmentation: By Country
- 5.8.1 United States Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 5.8.1.1 United States Incretin-Based Drugs Market, By Drug Type
  - 5.8.1.2 United States Incretin-Based Drugs Market, By Route of Administration
  - 5.8.1.3 United States Incretin-Based Drugs Market, By Indication
- 5.8.2 Canada Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 5.8.2.1 Canada Incretin-Based Drugs Market, By Drug Type
  - 5.8.2.2 Canada Incretin-Based Drugs Market, By Route of Administration
  - 5.8.2.3 Canada Incretin-Based Drugs Market, By Indication
- 5.8.3 Rest of Americas Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 5.8.3.1 Rest of Americas Incretin-Based Drugs Market, By Drug Type
  - 5.8.3.2 Rest of Americas Incretin-Based Drugs Market, By Route of Administration
  - 5.8.3.3 Rest of Americas Incretin-Based Drugs Market, By Indication

6. Europe Incretin Based Drugs Market: Historic and Forecast (2018-2028)

6.1 Europe Incretin-Based Drugs Market: Snapshot
6.2 Europe Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.3 Europe Incretin-Based Drugs Market: Key Factors
6.4 Europe Incretin-Based Drugs Market: Segment Analysis
6.5 Europe Incretin-Based Drugs Market Segmentation: By Drug Type
- 6.5.1 Europe Incretin-Based Drugs Market, By Drug Type Overview
- 6.5.2 Europe Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
- 6.5.3 Europe Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
6.6 Europe Incretin-Based Drugs Market Segmentation: By Route of Administration
- 6.6.1 Europe Incretin-Based Drugs Market, By Route of Administration Overview
- 6.6.2 Europe Incretin-Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
- 6.6.3 Europe Incretin-Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
6.7 Europe Incretin-Based Drugs Market Segmentation: By Indication
- 6.7.1 Europe Incretin-Based Drugs Market, By Indication Overview
- 6.7.2 Europe Incretin-Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
- 6.7.3 Europe Incretin-Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
6.8 Europe Incretin-Based Drugs Market Segmentation: By Country
- 6.8.1 Germany Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 6.8.1.1 Germany Incretin-Based Drugs Market, By Drug Type
  - 6.8.1.2 Germany Incretin Based Drugs Market, By Route of Administration
  - 6.8.1.3 Germany Incretin Based Drugs Market, By Indication
- 6.8.2 United Kingdom Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 6.8.2.1 United Kingdom Incretin Based Drugs Market, By Drug Type
  - 6.8.2.2 United Kingdom Incretin Based Drugs Market, By Route of Administration
  - 6.8.2.3 United Kingdom Incretin Based Drugs Market, By Indication
- 6.8.3 France Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 6.8.3.1 France Incretin Based Drugs Market, By Drug Type
  - 6.8.3.2 France Incretin Based Drugs Market, By Route of Administration
  - 6.8.3.3 France Incretin Based Drugs Market, By Indication
- 6.8.4 Italy Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 6.8.4.1 Italy Incretin Based Drugs Market, By Drug Type
  - 6.8.4.2 Italy Incretin Based Drugs Market, By Route of Administration
  - 6.8.4.3 Italy Incretin Based Drugs Market, By Indication
- 6.8.5 Spain Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 6.8.5.1 Spain Incretin Based Drugs Market, By Drug Type
  - 6.8.5.2 Spain Incretin Based Drugs Market, By Route of Administration
  - 6.8.5.3 Spain Incretin Based Drugs Market, By Indication
- 6.8.6 Rest of Europe Incretin-Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 6.8.6.1 Rest of Europe Incretin-Based Drugs Market, By Drug Type
  - 6.8.6.2 Rest of Europe Incretin-Based Drugs Market, By Route of Administration
  - 6.8.6.3 Rest of Europe Incretin-Based Drugs Market, By Indication

7. Asia-Pacific Incretin Based Drugs Market: Historic and Forecast (2018-2028)

7.1 Asia-Pacific Incretin Based Drugs Market: Snapshot
7.2 Asia-Pacific Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.3 Asia-Pacific Incretin Based Drugs Market: Key Factors
7.4 Asia-Pacific Incretin Based Drugs Market: Segment Analysis
7.5 Asia-Pacific Incretin Based Drugs Market Segmentation: By Drug Type
- 7.5.1 Asia-Pacific Incretin Based Drugs Market, By Drug Type Overview
- 7.5.2 Asia-Pacific Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
- 7.5.3 Asia-Pacific Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
7.6 Asia-Pacific Incretin Based Drugs Market Segmentation: By Route of Administration
- 7.6.1 Asia-Pacific Incretin Based Drugs Market, By Route of Administration Overview
- 7.6.2 Asia-Pacific Incretin Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
- 7.6.3 Asia-Pacific Incretin Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
7.7 Asia-Pacific Incretin Based Drugs Market Segmentation: By Indication
- 7.7.1 Asia-Pacific Incretin Based Drugs Market, By Indication Overview
- 7.7.2 Asia-Pacific Incretin Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
- 7.7.3 Asia-Pacific Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)
7.8 Asia-Pacific Incretin Based Drugs Market Segmentation: By Country
- 7.8.1 China Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 7.8.1.1 China Incretin Based Drugs Market, By Drug Type
  - 7.8.1.2 China Incretin Based Drugs Market, By Route of Administration
  - 7.8.1.3 China Incretin Based Drugs Market, By Indication
- 7.8.2 Japan Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 7.8.1.1 Japan Incretin Based Drugs Market, By Drug Type
  - 7.8.1.2 Japan Incretin Based Drugs Market, By Route of Administration
  - 7.8.1.3 Japan Incretin Based Drugs Market, By Indication
- 7.8.3 India Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 7.8.3.1 India Incretin Based Drugs Market, By Drug Type
  - 7.8.3.2 India Incretin Based Drugs Market, By Route of Administration
  - 7.8.3.3 India Incretin Based Drugs Market, By Indication
- 7.8.5 Rest of Asia-Pacific Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
  - 7.8.5.1 Rest of Asia-Pacific Incretin Based Drugs Market, By Drug Type
  - 7.8.5.2 Rest of Asia-Pacific Incretin Based Drugs Market, By Route of Administration
  - 7.8.5.3 Rest of Asia-Pacific Incretin Based Drugs Market, By Indication

8. Middle-East & Africa Incretin Based Drugs Market: Historic and Forecast (2018-2028)

8.1 Middle-East & Africa Incretin Based Drugs Market: Snapshot
8.2 Middle-East & Africa Incretin Based Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
8.3 Middle-East & Africa Incretin Based Drugs Market: Key Factors
8.4 Middle-East & Africa Incretin Based Drugs Market: Segment Analysis
8.5 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Drug Type
- 8.5.1 Middle-East & Africa Incretin Based Drugs Market, By Drug Type Overview
- 8.5.2 Middle-East & Africa Incretin Based Drugs Market Size, By Glucagon-like Peptide-1 Receptor Agonists, By Value, 2018H-2028F (USD Billion & CAGR)
- 8.5.3 Middle-East & Africa Incretin Based Drugs Market Size, By Dipeptidyl Peptidase-4 Inhibitors, By Value, 2018H-2028F (USD Billion & CAGR)
8.6 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Route of Administration
- 8.6.1 Middle-East & Africa Incretin Based Drugs Market, By Route of Administration Overview
- 8.6.2 Middle-East & Africa Incretin Based Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)
- 8.6.3 Middle-East & Africa Incretin Based Drugs Market Size, By Injectables, By Value, 2018H-2028F (USD Billion & CAGR)
8.7 Middle-East & Africa Incretin Based Drugs Market Segmentation: By Indication
- 8.7.1 Middle-East & Africa Incretin Based Drugs Market, By Indication: Overview
- 8.7.2 Middle-East & Africa Incretin Based Drugs Market Size, By Diabetes, By Value, 2018H-2028F (USD Billion & CAGR)
- 8.7.3 Middle-East & Africa Incretin Based Drugs Market Size, By Obesity, By Value, 2018H-2028F (USD Billion & CAGR)

9. Market Dynamics

9.1 Impact Assessment of Market Dynamics on Global Incretin-Based Drugs Market
9.2 Drivers
9.3 Restraints
9.4 Trends

10. Porter's Five Forces Analysis

10.1 Porter's Five Forces Model

11. Competitive Positioning

11.1 Companies' Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Incretin-Based Drugs Market
11.4 Company Profiles
- 11.4.1 Eli Lilly and Company
- 11.4.2 Boehringer Ingelheim
- 11.4.3 Novo Nordisk
- 11.4.4 AstraZeneca PLC
- 11.4.5 Merck & Co., Inc.
- 11.4.6 Pfizer
- 11.4.7 Novartis AG
- 11.4.8 Takeda Pharmaceuticals
- 11.4.9 Bristol Myers Squibb
- 11.4.10 Structure Therapeutics

インクレチン関連薬の世界市場：医薬品タイプ別、投与経路別、適応症別、地域別、国別の分析、市場の考察と予測

Global Incretin Based Drugs Market : Analysis By Drug Type, Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast

目次

第1章市場の背景

第2章戦略的推奨事項

第3章世界のインクレチン関連薬市場：実績と予測（2018年～2028年）

第4章世界のインクレチン関連薬市場、地域分析

第5章南北アメリカのインクレチン関連薬市場：実績と予測（2018年～2028年）

第6章欧州のインクレチン関連薬市場：実績と予測（2018年～2028年）

第7章アジア太平洋のインクレチン関連薬市場：実績と予測（2018年～2028年）

第8章中東・アフリカのインクレチン関連薬市場：実績と予測（2018年～2028年）

第9章市場力学

第10章ポーターのファイブフォース分析

第11章競合のポジショニング

List of Figures

List of Figures

Executive Summary

Scope of the Report

Table of Contents

1. Market Background

2. Strategic Recommendations

3. Global Incretin Based Drugs Market: Historic and Forecast (2018-2028)

4. Global Incretin Based Drugs Market, Region Analysis

5. Americas Incretin Based Drugs Market: Historic and Forecast (2018-2028)

6. Europe Incretin Based Drugs Market: Historic and Forecast (2018-2028)

7. Asia-Pacific Incretin Based Drugs Market: Historic and Forecast (2018-2028)

8. Middle-East & Africa Incretin Based Drugs Market: Historic and Forecast (2018-2028)

9. Market Dynamics

10. Porter's Five Forces Analysis

11. Competitive Positioning

インクレチン関連薬の世界市場：医薬品タイプ別、投与経路別、適応症別、地域別、国別の分析、市場の考察と予測

Global Incretin Based Drugs Market : Analysis By Drug Type, Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast

目次

第1章 市場の背景

第2章 戦略的推奨事項

第3章 世界のインクレチン関連薬市場：実績と予測（2018年～2028年）

第4章 世界のインクレチン関連薬市場、地域分析

第5章 南北アメリカのインクレチン関連薬市場：実績と予測（2018年～2028年）

第6章 欧州のインクレチン関連薬市場：実績と予測（2018年～2028年）

第7章 アジア太平洋のインクレチン関連薬市場：実績と予測（2018年～2028年）

第8章 中東・アフリカのインクレチン関連薬市場：実績と予測（2018年～2028年）

第9章 市場力学

第10章 ポーターのファイブフォース分析

第11章 競合のポジショニング

List of Figures

List of Figures

Executive Summary

Scope of the Report

Table of Contents

1. Market Background

2. Strategic Recommendations

3. Global Incretin Based Drugs Market: Historic and Forecast (2018-2028)

4. Global Incretin Based Drugs Market, Region Analysis

5. Americas Incretin Based Drugs Market: Historic and Forecast (2018-2028)

6. Europe Incretin Based Drugs Market: Historic and Forecast (2018-2028)

7. Asia-Pacific Incretin Based Drugs Market: Historic and Forecast (2018-2028)

8. Middle-East & Africa Incretin Based Drugs Market: Historic and Forecast (2018-2028)

9. Market Dynamics

10. Porter's Five Forces Analysis

11. Competitive Positioning

第1章市場の背景

第2章戦略的推奨事項

第3章世界のインクレチン関連薬市場：実績と予測（2018年～2028年）

第4章世界のインクレチン関連薬市場、地域分析

第5章南北アメリカのインクレチン関連薬市場：実績と予測（2018年～2028年）

第6章欧州のインクレチン関連薬市場：実績と予測（2018年～2028年）

第7章アジア太平洋のインクレチン関連薬市場：実績と予測（2018年～2028年）

第8章中東・アフリカのインクレチン関連薬市場：実績と予測（2018年～2028年）

第9章市場力学

第10章ポーターのファイブフォース分析

第11章競合のポジショニング